发明名称 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
摘要 An object of the present invention is to provide an antagonist against CRF receptors which is effective as a therapeutic or prophylactic agent for diseases in which CRF is considered to be involved, such as depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastric diseases, drug dependence, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, cephalic external wound, inflammation, immunity-related diseases, alopecia, irritable bowel syndrome, sleep disorders, epilepsy, dermatitides, schizophrenia, etc. [SOLUTION] A pyrrolopyrimidine or pyrrolopyridine derivative substituted with a cyclic amino group represented by the following formula [I]: has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved.
申请公布号 EP1787992(A1) 申请公布日期 2007.05.23
申请号 EP20060019987 申请日期 2003.12.24
申请人 TAISHO PHARMACEUTICAL CO., LTD 发明人 NAKAZATO, ATSURO;OKUBO, TAKETOSHI;NOZAWA, DAI;YAMAGUCHI, MIKAKO;TAMITA, TOMOKO;KENNIS, LUDO E. J.;DE BRUYN, MARCEL F.L.;BONGARTZ, JEAN-PIERRE A. M.;VAN DEN KEYBUS, FRANS M.A.;VAN ROOSBROECK, YVES E.M.;LUYCKX, MARCEL G.M.;HENDRICKX, ROBERT J.M.
分类号 C07D487/04;A61K31/436;A61K31/437;A61K31/4375;A61K31/439;A61K31/519;A61K31/661;A61P1/00;A61P1/04;A61P9/10;A61P9/12;A61P17/00;A61P17/14;A61P25/00;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/36;A61P29/00;A61P37/00;A61P43/00;C07D209/00;C07D221/00;C07D239/00;C07D451/00;C07D471/00;C07D471/04;C07D471/08;C07D487/00;C07D491/00;C07D491/08;C07D519/00;C07F9/59;C07F9/6561 主分类号 C07D487/04
代理机构 代理人
主权项
地址